유럽의 기침캔디 시장(2021-2031년) : 범위, 세분화, 동향, 경쟁 분석

The Europe Cough Drops Market is projected to grow significantly, reaching approximately US$ 1,085.56 million by 2031, up from US$ 669.47 million in 2023, with a compound annual growth rate (CAGR) of 6.2% during the forecast period from 2023 to 2031.

Executive Summary and Market Analysis

The demand for cough drops in Europe is increasing, driven by heightened health awareness and a growing need for relief from colds and sore throats, particularly in colder seasons. Key European nations such as Germany, the UK, and France are benefiting from robust healthcare systems and a trend towards natural ingredients like eucalyptus and honey, aligning with the broader movement towards healthier lifestyles.

As the population ages and air pollution rises, more individuals are facing chronic throat and respiratory issues, leading to a surge in demand for soothing products. Prominent brands like Ricola, Strepsils (from Reckitt), and Jakemans are responding by introducing innovative options, including sugar-free varieties and formulations aimed at enhancing immunity.

Market Segmentation Analysis

The Europe cough drops market can be segmented based on product type, application, and distribution channel:

• By Product: The market is divided into gluten-free, sugar-free, and other categories. In 2023, sugar-free cough drops held the largest market share.
• By Application: The market is categorized into adults and children, with adults representing a larger share in 2023.
• By Distribution Channel: The market is split into offline and online channels, with offline sales dominating in 2023. The offline segment includes retail pharmacies, supermarkets or hypermarkets, and hospital pharmacies.

Market Outlook

Cough drops are over-the-counter products designed to alleviate coughing and soothe sore throats. They are widely available in supermarkets, pharmacies, and convenience stores, making them an attractive option for individuals seeking quick relief without needing a prescription. Their affordability and accessibility appeal to consumers looking for solutions while at work, traveling, or managing daily activities.

The rise of the internet, healthcare apps, and social media has facilitated easy access to health information. Consumers can quickly research symptoms like coughs and sore throats online and discover over-the-counter remedies such as cough drops. Influencers and health blogs often recommend products, enhancing consumer confidence in self-medication. Additionally, there is a growing trend towards preventative healthcare, with consumers actively seeking ways to manage mild symptoms at home before they escalate. Cough drops are increasingly viewed as a convenient and effective method for addressing coughs and sore throats, especially during cold and flu seasons. This shift towards self-medication is propelling the cough drops market as consumers look for practical, affordable solutions for mild symptoms.

Country Insights

The Europe cough drops market includes countries such as the UK, Germany, France, Italy, Spain, and others. The UK accounted for the largest market share in 2023.

As health consciousness rises, there is a growing demand for sugar-free and natural cough drops, prompting brands to innovate and expand their offerings with organic and herbal options. This trend significantly influences the market by fostering competition and enhancing brand loyalty. Leading brands like Strepsils, Halls, and Fisherman's Friend dominate the UK market, providing a variety of formulations that incorporate soothing ingredients such as menthol, eucalyptus, and honey. Furthermore, the rise of e-commerce has transformed how consumers purchase cough drops, making it easier to access these products.

Company Profiles

Key players in the Europe cough drops market include Bliss GVS Pharma Ltd, Cipla Ltd, Gepach International, GSK Plc, Mondelez International Inc, Reckitt Benckiser Group Plc, Ricola, Sanofi SA, The Procter & Gamble Co, and Thornton & Ross, among others. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their product offerings and increase market share.

Table Of Contents

1. Introduction

• 1.1 Report Guidance
• 1.2 Market Segmentation

2. Executive Summary

• 2.1 Key Insights

3. Research Methodology

• 3.1 Secondary Research
• 3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macroeconomic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country-level data:
• 3.3 Assumptions and Limitations

4. Europe Cough Drops Market Landscape

• 4.1 Overview
• 4.2 PEST Analysis

5. Europe Cough Drops Market - Key Market Dynamics

• 5.1 Europe Cough Drops Market - Key Market Dynamics
• 5.2 Market Drivers
  • 5.2.1 Rising Burden of Respiratory Diseases Causing Sore Throat
  • 5.2.2 Increasing Shift Toward Self-Medication
• 5.3 Market Restraints
  • 5.3.1 Inability to Provide Long-Term Relief and Availability of Alternatives
• 5.4 Market Opportunities
  • 5.4.1 Focus on Natural Ingredients and Sustainable Packaging
• 5.5 Future Trends
  • 5.5.1 Adoption of Innovative Marketing Strategies
• 5.6 Impact of Drivers and Restraints:

6. Europe Cough Drops Market - Analysis

• 6.1 Europe Cough Drops Market Revenue (US$ Million), 2021-2031
• 6.2 Europe Cough Drops Market Forecast Analysis

7. Europe Cough Drops Market Analysis - by Product

• 7.1 Gluten Free
  • 7.1.1 Overview
  • 7.1.2 Gluten Free: Europe Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 7.2 Sugar Free
  • 7.2.1 Overview
  • 7.2.2 Sugar Free: Europe Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 7.3 Others
  • 7.3.1 Overview
  • 7.3.2 Others: Europe Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Europe Cough Drops Market Analysis - by Application

• 8.1 Adults
  • 8.1.1 Overview
  • 8.1.2 Adults: Europe Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 8.2 Children
  • 8.2.1 Overview
  • 8.2.2 Children: Europe Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Europe Cough Drops Market Analysis - by Distribution Channel

• 9.1 Offline
  • 9.1.1 Overview
  • 9.1.2 Offline: Europe Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
• 9.2 Online
  • 9.2.1 Overview
  • 9.2.2 Online: Europe Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Europe Cough Drops Market - Country Analysis

• 10.1 Europe
  • 10.1.1 Europe Cough Drops Market - Revenue and Forecast Analysis - by Country
    • 10.1.1.1 Europe Cough Drops Market - Revenue and Forecast Analysis - by Country
    • 10.1.1.2 United Kingdom: Europe Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 10.1.1.2.1 United Kingdom: Europe Cough Drops Market Share - by Product
      • 10.1.1.2.2 United Kingdom: Europe Cough Drops Market Share - by Application
      • 10.1.1.2.3 United Kingdom: Europe Cough Drops Market Share - by Distribution Channel
      • 10.1.1.2.4 United Kingdom: Europe Cough Drops Market Share - by Offline
    • 10.1.1.3 Germany: Europe Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 10.1.1.3.1 Germany: Europe Cough Drops Market Share - by Product
      • 10.1.1.3.2 Germany: Europe Cough Drops Market Share - by Application
      • 10.1.1.3.3 Germany: Europe Cough Drops Market Share - by Distribution Channel
      • 10.1.1.3.4 Germany: Europe Cough Drops Market Share - by Offline
    • 10.1.1.4 France: Europe Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 10.1.1.4.1 France: Europe Cough Drops Market Share - by Product
      • 10.1.1.4.2 France: Europe Cough Drops Market Share - by Application
      • 10.1.1.4.3 France: Europe Cough Drops Market Share - by Distribution Channel
      • 10.1.1.4.4 France: Europe Cough Drops Market Share - by Offline
    • 10.1.1.5 Italy: Europe Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 10.1.1.5.1 Italy: Europe Cough Drops Market Share - by Product
      • 10.1.1.5.2 Italy: Europe Cough Drops Market Share - by Application
      • 10.1.1.5.3 Italy: Europe Cough Drops Market Share - by Distribution Channel
      • 10.1.1.5.4 Italy: Europe Cough Drops Market Share - by Offline
    • 10.1.1.6 Spain: Europe Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 10.1.1.6.1 Spain: Europe Cough Drops Market Share - by Product
      • 10.1.1.6.2 Spain: Europe Cough Drops Market Share - by Application
      • 10.1.1.6.3 Spain: Europe Cough Drops Market Share - by Distribution Channel
      • 10.1.1.6.4 Spain: Europe Cough Drops Market Share - by Offline
    • 10.1.1.7 Rest of Europe: Europe Cough Drops Market - Revenue and Forecast, 2021-2031 (US$ Million)
      • 10.1.1.7.1 Rest of Europe: Europe Cough Drops Market Share - by Product
      • 10.1.1.7.2 Rest of Europe: Europe Cough Drops Market Share - by Application
      • 10.1.1.7.3 Rest of Europe: Europe Cough Drops Market Share - by Distribution Channel
      • 10.1.1.7.4 Rest of Europe: Europe Cough Drops Market Share - by Offline

11. Industry Landscape

• 11.1 Overview
• 11.2 Growth Strategies in Cough Drops Market
• 11.3 Organic Growth Strategies
  • 11.3.1 Overview
• 11.4 Inorganic Growth Strategies
  • 11.4.1 Overview

12. Company Profiles

• 12.1 Mondelez International Inc
  • 12.1.1 Key Facts
  • 12.1.2 Business Description
  • 12.1.3 Products and Services
  • 12.1.4 Financial Overview
  • 12.1.5 SWOT Analysis
  • 12.1.6 Key Developments
• 12.2 The Procter & Gamble Co
  • 12.2.1 Key Facts
  • 12.2.2 Business Description
  • 12.2.3 Products and Services
  • 12.2.4 Financial Overview
  • 12.2.5 SWOT Analysis
  • 12.2.6 Key Developments
• 12.3 GSK Plc
  • 12.3.1 Key Facts
  • 12.3.2 Business Description
  • 12.3.3 Products and Services
  • 12.3.4 Financial Overview
  • 12.3.5 SWOT Analysis
  • 12.3.6 Key Developments
• 12.4 Cipla Ltd
  • 12.4.1 Key Facts
  • 12.4.2 Business Description
  • 12.4.3 Products and Services
  • 12.4.4 Financial Overview
  • 12.4.5 SWOT Analysis
  • 12.4.6 Key Developments
• 12.5 Bliss GVS Pharma Ltd
  • 12.5.1 Key Facts
  • 12.5.2 Business Description
  • 12.5.3 Products and Services
  • 12.5.4 Financial Overview
  • 12.5.5 SWOT Analysis
  • 12.5.6 Key Developments
• 12.6 Thornton & Ross
  • 12.6.1 Key Facts
  • 12.6.2 Business Description
  • 12.6.3 Products and Services
  • 12.6.4 Financial Overview
  • 12.6.5 SWOT Analysis
  • 12.6.6 Key Developments
• 12.7 Reckitt Benckiser Group Plc
  • 12.7.1 Key Facts
  • 12.7.2 Business Description
  • 12.7.3 Financial Overview
  • 12.7.4 SWOT Analysis
  • 12.7.5 Key Developments
• 12.8 Sanofi SA
  • 12.8.1 Key Facts
  • 12.8.2 Business Description
  • 12.8.3 Products and Services
  • 12.8.4 Financial Overview
  • 12.8.5 SWOT Analysis
  • 12.8.6 Key Developments
• 12.9 Gepach International
  • 12.9.1 Key Facts
  • 12.9.2 Business Description
  • 12.9.3 Products and Services
  • 12.9.4 Financial Overview
  • 12.9.5 SWOT Analysis
  • 12.9.6 Key Developments
• 12.10 Ricola
  • 12.10.1 Key Facts
  • 12.10.2 Business Description
  • 12.10.3 Products and Services
  • 12.10.4 Financial Overview
  • 12.10.5 SWOT Analysis
  • 12.10.6 Key Developments

13. Appendix

• 13.1 About The Insight Partners
• 13.2 Glossary of Terms